B-type natriuretic peptide, a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients
- 30 September 2008
- journal article
- Published by Elsevier BV in Diabetes & Metabolism
- Vol. 34 (4), 355-362
- https://doi.org/10.1016/j.diabet.2008.02.004
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- No evidence for left ventricular diastolic dysfunction in asymptomatic normotensive type 2 diabetic patients: a case-control study with new echocardiographic techniquesDiabetes & Metabolism, 2007
- Left ventricular diastolic (dys)function in type 2 diabetes: time for a critical reappraisalDiabetes & Metabolism, 2007
- Cross-Sectional Relations of Multiple Biomarkers From Distinct Biological Pathways to Brachial Artery Endothelial FunctionCirculation, 2006
- Impaired Coronary Endothelium–Dependent Vasodilation Is Associated With Microalbuminuria in Patients With Type 2 Diabetes and Angiographically Normal Coronary ArteriesDiabetes Care, 2006
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004
- B-Type Natriuretic Peptide — A Biomarker for All Seasons?New England Journal of Medicine, 2004
- Hypertension Management in Adults With DiabetesDiabetes Care, 2004
- Plasma Brain Natriuretic Peptide Levels in Normotensive Noninsulin-Dependent Diabetic Patients with MicroalbuminuriaJournal of Clinical Endocrinology & Metabolism, 1999
- Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registryThe American Journal of Cardiology, 1996
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974